134 related articles for article (PubMed ID: 1835012)
1. [Prevention and treatment of materno-fetal toxoplasmosis].
Fortier B; Ajana F; Pinto de Sousa MI; Aissi E; Camus D
Presse Med; 1991 Sep; 20(29):1374-83. PubMed ID: 1835012
[TBL] [Abstract][Full Text] [Related]
2. [Management of congenital toxoplasmosis in France: current data].
Garcia-Méric P; Franck J; Dumon H; Piarroux R
Presse Med; 2010 May; 39(5):530-8. PubMed ID: 19926248
[TBL] [Abstract][Full Text] [Related]
3. [Prevention of congenital toxoplasmosis].
Russo M; Galanti B
Clin Ter; 1990 Sep; 134(6):383-92. PubMed ID: 2149535
[TBL] [Abstract][Full Text] [Related]
4. Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests.
Bessières MH; Berrebi A; Rolland M; Bloom MC; Roques C; Cassaing S; Courjault C; Séguéla JP
Eur J Obstet Gynecol Reprod Biol; 2001 Jan; 94(1):37-45. PubMed ID: 11134824
[TBL] [Abstract][Full Text] [Related]
5. [Current status of research on the prevention of congenital toxoplasmosis].
Iygiste AK; Zasukhin DN
Sov Med; 1971; 34(12):22-7. PubMed ID: 5004616
[No Abstract] [Full Text] [Related]
6. [The Spanish Society of Pediatric Infectious Diseases Guidelines for the diagnosis and treatment of congenital toxoplasmosis].
Baquero-Artigao F; del Castillo Martín F; Fuentes Corripio I; Goncé Mellgren A; Fortuny Guasch C; de la Calle Fernández-Miranda M; González-Tomé MI; Couceiro Gianzo JA; Neth O; Ramos Amador JT;
An Pediatr (Barc); 2013 Aug; 79(2):116.e1-116.e16. PubMed ID: 23352717
[TBL] [Abstract][Full Text] [Related]
7. Toxoplasmosis screening during pregnancy in France: Opinion of an expert panel for the CNGOF.
Picone O; Fuchs F; Benoist G; Binquet C; Kieffer F; Wallon M; Wehbe K; Mandelbrot L; Villena I
J Gynecol Obstet Hum Reprod; 2020 Sep; 49(7):101814. PubMed ID: 32428782
[TBL] [Abstract][Full Text] [Related]
8. Congenital toxoplasmosis and prenatal care state programs.
Avelino MM; Amaral WN; Rodrigues IM; Rassi AR; Gomes MB; Costa TL; Castro AM
BMC Infect Dis; 2014 Jan; 14():33. PubMed ID: 24438336
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic problems and postnatal follow-up in congenital toxoplasmosis.
Mazzola A; Casuccio A; Romano A; Schimmenti MG; Titone L; Di Carlo P
Minerva Pediatr; 2007 Jun; 59(3):207-13. PubMed ID: 17519865
[TBL] [Abstract][Full Text] [Related]
10. [Toxoplasmosis in pregnancy: Practical Management].
Mandelbrot L; Kieffer F; Wallon M; Winer N; Massardier J; Picone O; Fuchs F; Benoist G; Garcia-Meric P; L'Ollivier C; Paris L; Piarroux R; Villena I; Peyron F
Gynecol Obstet Fertil Senol; 2021 Oct; 49(10):782-791. PubMed ID: 33677120
[TBL] [Abstract][Full Text] [Related]
11. Toxoplasmosis and pregnancy: the prevention of congenital toxoplasmosis.
Rondanelli EG; Carosi G; Filice G; Maccabruni A; Minoli L; Pecorari D
Int J Biol Res Pregnancy; 1981; 2(3):104-13. PubMed ID: 7333697
[TBL] [Abstract][Full Text] [Related]
12. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis.
Daffos F; Forestier F; Capella-Pavlovsky M; Thulliez P; Aufrant C; Valenti D; Cox WL
N Engl J Med; 1988 Feb; 318(5):271-5. PubMed ID: 3336419
[TBL] [Abstract][Full Text] [Related]
13. IgM ELISA follow-up of spiramycin treatment for toxoplasmosis: should the drug be prescribed in India?
Singh S
J Assoc Physicians India; 1992 Feb; 40(2):140. PubMed ID: 1629136
[No Abstract] [Full Text] [Related]
14. Prevention, diagnosis, and treatment of fetal toxoplasmosis.
Matsui D
Clin Perinatol; 1994 Sep; 21(3):675-89. PubMed ID: 7982341
[TBL] [Abstract][Full Text] [Related]
15. [Strategies for the diagnosis and treatment of prenatal toxoplasmosis - a survey].
Christoph J; Kattner E; Seitz HM; Reiter-Owona I
Z Geburtshilfe Neonatol; 2004 Feb; 208(1):10-6. PubMed ID: 15039886
[TBL] [Abstract][Full Text] [Related]
16. Difficulties in the diagnosis of congenital toxoplasmosis by cordocentesis. Case report.
Holliman RE; Johnson JD; Constantine G; Bissenden JG; Nicolaides K; Savva D
Br J Obstet Gynaecol; 1991 Aug; 98(8):832-4. PubMed ID: 1911595
[No Abstract] [Full Text] [Related]
17. Congenital toxoplasmosis: efficacy of maternal treatment with spiramycin alone.
Vergani P; Ghidini A; Ceruti P; Strobelt N; Spelta A; Zapparoli B; Rescaldani R
Am J Reprod Immunol; 1998 May; 39(5):335-40. PubMed ID: 9602252
[TBL] [Abstract][Full Text] [Related]
18. In utero treatment of toxoplasmic fetopathy with the combination pyrimethamine-sulfadiazine.
Couvreur J; Thulliez P; Daffos F; Aufrant C; Bompard Y; Gesquière A; Desmonts G
Fetal Diagn Ther; 1993; 8(1):45-50. PubMed ID: 8452648
[TBL] [Abstract][Full Text] [Related]
19. [Significance of post-partum diagnosis of congenital toxoplasmosis primary maternal infection at the end of the pregnancy].
Wirden M; Botterel F; Romand S; Ithier G; Bourée P
J Gynecol Obstet Biol Reprod (Paris); 1999 Oct; 28(6):566-7. PubMed ID: 10598352
[TBL] [Abstract][Full Text] [Related]
20. [Use of the ISAGA method in detection of specific IgM, IgA, IgE antibodies in acquired and congenital toxoplasmosis].
Paul M
Wiad Parazytol; 1997; 43(1):39-51. PubMed ID: 9289926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
